n(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine has been researched along with adenosine in 6 studies
Studies (n(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine) | Trials (n(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine) | Recent Studies (post-2010) (n(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
---|---|---|---|---|---|
6 | 0 | 0 | 32,536 | 1,075 | 8,930 |
Protein | Taxonomy | n(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine (IC50) | adenosine (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dunwiddie, TV; Fredholm, BB; Jonzon, B; Sandberg, G | 1 |
Paul, SM; Skolnick, P | 1 |
Williams, M | 1 |
Irmscher, K; Jones, R; Lock, KL; Marangos, PJ; Paul, SM; Skolnick, P | 1 |
Borbe, HO; Fehske, KJ; Müller, WE; Wollert, U; Zube, I | 1 |
Lock, KL; Marangos, P; Paugh, B; Paul, S; Skolnick, P; Windsor, R | 1 |
2 review(s) available for n(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine and adenosine
Article | Year |
---|---|
The mechanism(s) of action of the benzodiazepines.
Topics: Adenosine; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Caffeine; Carbolines; Cats; Cattle; Diazepam; gamma-Aminobutyric Acid; Humans; Molecular Weight; Muscle Relaxation; Neurotransmitter Agents; Niacinamide; Purines; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Neurotransmitter; Seizures; Sleep Wake Disorders | 1981 |
Anxioselective anxiolytics.
Topics: Adenosine; Animals; Anti-Anxiety Agents; Anxiety; Azabicyclo Compounds; Benzodiazepines; Brain Chemistry; Drug Interactions; Etazolate; gamma-Aminobutyric Acid; Humans; Molecular Weight; Piperazines; Pyrazoles; Pyridazines; Quinolines; Receptors, Cell Surface; Receptors, GABA-A; Structure-Activity Relationship | 1983 |
4 other study(ies) available for n(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine and adenosine
Article | Year |
---|---|
The adenosine receptor activity of EMD 28422, a purine derivative with reported actions on benzodiazepine receptors.
Topics: Adenosine; Adipose Tissue; Animals; Body Temperature; Cats; Chromatography, High Pressure Liquid; Cyclic AMP; Electric Stimulation; Electrophysiology; Guinea Pigs; Hippocampus; In Vitro Techniques; Lipolysis; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Purinergic; T-Lymphocytes; Time Factors | 1985 |
Increased benzodiazepine receptor number elicited in vitro by a novel purine, EMD 28422.
Topics: Adenosine; Animals; Binding Sites; Brain; Diazepam; In Vitro Techniques; Male; Muscimol; Purines; Radioligand Assay; Rats; Receptors, Cell Surface; Receptors, Drug; Receptors, GABA-A; Tritium | 1980 |
Beta-carboline binding indicates the presence of benzodiazepine receptor subclasses in the bovine central nervous system.
Topics: Adenosine; Animals; Binding Sites; Brain Chemistry; Carbolines; Cattle; gamma-Aminobutyric Acid; Indoles; Receptors, Drug; Receptors, GABA-A; Substrate Specificity | 1982 |
Pharmacologic and behavioral effects of EMD 28422: a novel purine which enhances (3H) diazepam binding to brain benzodiazepine receptors.
Topics: Adenosine; Animals; Anticonvulsants; Benzodiazepines; Binding Sites; Brain; Conflict, Psychological; Diazepam; Male; Mice; Mice, Inbred C3H; Motor Activity; Rats; Receptors, Drug | 1980 |